Search
Now showing items 1-1 of 1
Early shift from ranibizumab to aflibercept for resistant pigment epitelial detachment in classical choroidal neovascularization
(International Journal of Ophthalmology (c/o Editorial Office), 2017)
AIM: To evaluate the therapeutic effect of aflibercept in patients with suboptimal response to ranibizumab therapy in the early period. METHOD: Thirty-eight patients with wet type age related macular degeneration(W-AMD) ...